Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

More realistic model hopes to replace animal testing
Nottingham researchers work on improving model of drug uptake

New research at the University of Nottingham aims to develop a more realistic model of drug uptake, which could offer an alternative to animal testing.

Led by Dr Martin Garnett at the university's School of Pharmacy, the research team are looking to deliver an improved cell-based model for determining how easily drugs and nanoparticles enter the body through the gut.

The three-year project has been granted funding of £152,780 by the Dr Hadwen Trust, a research charity that promotes and funds the development of techniques to replace animal testing in biomedical research.

Dr Garnett says that cell models which study drug uptake across the gut already exist. Commenting on the current research, he explained: "This work builds on previous work funded by the Dr Hadwen Trust where we investigated a component called ‘basement membrane’ which is present in normal gut, but absent in the conventional cell model.

"We have shown that basement membrane is important for both the normal growth of epithelial cells and as a barrier to uptake of some molecules and nanoparticles. In our new work we will extend these findings to produce a more realistic model."

An important part of the new study will be demonstrating and validating the beneficial effects of the basement membrane to the model.

To help improve its accuracy, scientists will incorporate M cells into the new model, as these have been found to help transport some nanoparticles. In addition, researchers say that the mucus produced by some cells in the epithelium can affect how quickly drugs pass into the gut.

The older model, according to the research team, uses a porous artificial membrane, or substrate, which has been found to prevent the movement of some larger molecules and particles. In the new model this substrate will be replaced with an innovative new support made from woven nanofibres.

Scientists say the new model could potentially reduce the need for animal testing, both in the pharmaceutical industry, and for toxicology studies on nano particles.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.